These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22273498)

  • 1. Effects of a long-pulsed 800-nm diode laser on axillary hyperhidrosis: a randomized controlled half-side comparison study.
    Bechara FG; Georgas D; Sand M; Stücker M; Othlinghaus N; Altmeyer P; Gambichler T
    Dermatol Surg; 2012 May; 38(5):736-40. PubMed ID: 22273498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
    Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of focal axillary hyperhidrosis using a long-pulsed Nd:YAG 1064 nm laser at hair reduction settings.
    Letada PR; Landers JT; Uebelhoer NS; Shumaker PR
    J Drugs Dermatol; 2012 Jan; 11(1):59-63. PubMed ID: 22206078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of subcutaneous sweat gland suction curettage for axillary hyperhidrosis: a prospective gravimetrically controlled study.
    Darabaneanu S; Darabaneanu HA; Niederberger U; Russo PA; Lischner S; Hauschild A
    Dermatol Surg; 2008 Sep; 34(9):1170-7; discussion 1177. PubMed ID: 18518888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser.
    Tierney E; Hanke CW
    Lasers Surg Med; 2009 Oct; 41(8):555-62. PubMed ID: 19746429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
    Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
    J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of laser therapy on axillary hyperhidrosis after one year follow-up: a randomized blinded controlled trial.
    Leclère FM; Moreno-Moraga J; Alcolea JM; Vogt PM; Royo J; Cornejo P; Casoli V; Mordon S; Trelles MA
    Lasers Surg Med; 2015 Feb; 47(2):173-9. PubMed ID: 25663083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study.
    Glaser DA; Coleman WP; Fan LK; Kaminer MS; Kilmer SL; Nossa R; Smith SR; O'Shaughnessy KF
    Dermatol Surg; 2012 Feb; 38(2):185-91. PubMed ID: 22289389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of axillary hyperhidrosis: a study comparing liposuction cannulas with a suction-curettage cannula.
    Bechara FG; Sand M; Sand D; Altmeyer P; Hoffmann K
    Ann Plast Surg; 2006 Jun; 56(6):654-7. PubMed ID: 16721080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis.
    Bechara FG; Sand M; Hoffmann K; Boorboor P; Altmeyer P; Stuecker M
    Dermatol Surg; 2008 Aug; 34(8):1001-9; discussion 1009. PubMed ID: 18430175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subdermal Nd-YAG laser for axillary hyperhidrosis.
    Goldman A; Wollina U
    Dermatol Surg; 2008 Jun; 34(6):756-62. PubMed ID: 18318722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, intra-individual controlled feasibility trial comparing the use of 1,470 and 940 nm diode laser for the treatment of hyperplastic inferior nasal turbinates.
    Havel M; Sroka R; Leunig A; Patel P; Betz CS
    Lasers Surg Med; 2011 Nov; 43(9):881-6. PubMed ID: 22006729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.